Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
Notified -
Globe Newswire4-12-2024, 14:00
Salsify Announces a New Connector to NIQ Brandbank, Empowering Brands to Deliver Accurate, Complete, and Compliant Product Content to Leading Global Retailers 1-11-2023, 19:00